Takeda Makes Bet on Viral Cancer-Killers in Deal With Turnstone

(Bloomberg) -- Takeda Pharmaceutical Co. is joining the search for a viral treatment that can hunt down and kill cancer cells, in a deal with closely held startup Turnstone Biologics Inc.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.